Christine E. Seidman's Insider Trades & SAST Disclosures
Christine E. Seidman's most recent trade in Merck & Co Inc was a trade of 71 Phantom Stock done . Disclosure was reported to the exchange on Sept. 30, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Christine E. Seidman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Merck & Co Inc
|
Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 71 | 14,977 | - | - | Phantom Stock | |
|
Merck & Co Inc
|
Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 65 | 14,815 | - | - | Phantom Stock | |
|
Merck & Co Inc
|
Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 1,752 | 14,749 | - | - | Phantom Stock | |
|
Merck & Co Inc
|
Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 61 | 12,920 | - | - | Phantom Stock | |
|
Merck & Co Inc
|
Christine Seidman E. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 74 | 12,775 | - | - | Phantom Stock | |
|
Merck & Co Inc
|
Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 78 | 12,612 | - | - | Phantom Stock | |
|
Merck & Co Inc
|
Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 70 | 12,451 | - | - | Phantom Stock | |
|
Merck & Co Inc
|
Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 1,980 | 12,381 | - | - | Phantom Stock | |
|
Merck & Co Inc
|
Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 76 | 10,339 | - | - | Phantom Stock | |
|
Merck & Co Inc
|
Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 73 | 10,192 | - | - | Phantom Stock | |
|
Merck & Co Inc
|
Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 94 | 10,039 | - | - | Phantom Stock | |
|
Merck & Co Inc
|
Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 89 | 9,871 | - | - | Phantom Stock | |
|
Merck & Co Inc
|
Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,363 | 9,782 | - | - | Phantom Stock | |
|
Merck & Co Inc
|
Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 198 | 7,362 | - | - | Phantom Stock | |
|
Merck & Co Inc
|
Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2021 | 212 | 7,105 | - | - | Phantom Stock | |
|
Merck & Co Inc
|
Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 216 | 6,840 | - | - | Phantom Stock | |
|
Merck & Co Inc
|
Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 208 | 6,571 | - | - | Phantom Stock | |
|
Merck & Co Inc
|
Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 2,635 | 6,173 | - | - | Phantom Stock | |
|
Merck & Co Inc
|
Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 210 | 3,509 | - | - | Phantom Stock | |
|
Merck & Co Inc
|
Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 195 | 3,054 | - | - | Phantom Stock | |
|
Merck & Co Inc
|
Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 210 | 2,837 | - | - | Phantom Stock | |
|
Merck & Co Inc
|
Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2020 | 2,477 | 2,627 | - | - | Phantom Stock | |
|
Merck & Co Inc
|
Christine E. Seidman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2020 | 36 | 150 | - | - | Phantom Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges